Literature DB >> 34201953

Changes in EEG Alpha Activity during Attention Control in Patients: Association with Sleep Disorders.

Anastasiya Runnova1,2, Anton Selskii1,2, Anton Kiselev1,3, Rail Shamionov4, Ruzanna Parsamyan1, Maksim Zhuravlev1,2.   

Abstract

We aimed to assess which quantitative EEG changes during daytime testing in patients with sleep disorder (primary insomnia and excessive daytime sleepiness groups). All experimental study participants were subjected to a long-term test for maintaining attention to sound stimuli, and their EEGs were recorded and then processed, using wavelet analysis, in order to estimate the power and frequency structure of alpha activity. In healthy subjects, the maximum increase in the alpha rhythm occurred near 9 Hz. Patients with primary insomnia were characterized by an increase in the amplitude of the alpha rhythm near 11 Hz. For subjects with sleep disorders, an increase in the amplitude of the alpha rhythm was observed in the entire frequency range (7.5-12.5 Hz), with a maximum increase at 9-10 Hz. Significant differences (p≤0.001) for changes in the alpha rhythm dynamics in the course of performing the attention test were observed in the frequency range of 7.5-10.5 Hz between the control group and patients with sleep disorders. The ratios of the alpha rhythm power values for passive stages with closed eyes before and after active stage were significantly different among the groups of healthy sleep volunteers, patients with primary insomnia, and patients with impaired sleep hygiene within the range of 9.5 to 12.5 Hz. The results of the current study supported the notion of a 24-h hyperarousal in primary insomnia.

Entities:  

Keywords:  EEG; alpha-activity; attention; insomnia; sleep disorder; wavelet-analyse

Year:  2021        PMID: 34201953     DOI: 10.3390/jpm11070601

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  40 in total

1.  Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects.

Authors:  E Stepanski; F Zorick; T Roehrs; D Young; T Roth
Journal:  Sleep       Date:  1988-02       Impact factor: 5.849

2.  Peak individual alpha frequency qualifies as a stable neurophysiological trait marker in healthy younger and older adults.

Authors:  Thomas H Grandy; Markus Werkle-Bergner; Christian Chicherio; Florian Schmiedek; Martin Lövdén; Ulman Lindenberger
Journal:  Psychophysiology       Date:  2013-04-03       Impact factor: 4.016

3.  Alpha-wave frequency characteristics in health and insomnia during sleep.

Authors:  Justus T C Schwabedal; Maik Riedl; Thomas Penzel; Niels Wessel
Journal:  J Sleep Res       Date:  2016-01-18       Impact factor: 3.981

4.  Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy.

Authors:  P D Nowell; S Mazumdar; D J Buysse; M A Dew; C F Reynolds; D J Kupfer
Journal:  JAMA       Date:  1997 Dec 24-31       Impact factor: 56.272

5.  Efficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trials.

Authors:  Hui Ling Soh; Roger C Ho; Cyrus S Ho; Wilson W Tam
Journal:  Sleep Med       Date:  2020-08-26       Impact factor: 3.492

6.  Resting-state quantitative EEG characteristics of insomniac patients with depression.

Authors:  Yunna Kwan; Chorom Baek; Sunhye Chung; Tae Hui Kim; Sungwon Choi
Journal:  Int J Psychophysiol       Date:  2018-01-11       Impact factor: 2.997

Review 7.  Computerised cognitive behavioural therapy for insomnia: a systematic review and meta-analysis.

Authors:  Sammy K Cheng; Janine Dizon
Journal:  Psychother Psychosom       Date:  2012-05-11       Impact factor: 17.659

8.  Not-only-a-title.

Authors:  Clare Bradley; Marcello Tamburini
Journal:  Health Qual Life Outcomes       Date:  2003-01-06       Impact factor: 3.186

Review 9.  Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration.

Authors:  Tania B Huedo-Medina; Irving Kirsch; Jo Middlemass; Markos Klonizakis; A Niroshan Siriwardena
Journal:  BMJ       Date:  2012-12-17

10.  Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist).

Authors:  Tomas Ros; Stefanie Enriquez-Geppert; Vadim Zotev; Kymberly D Young; Guilherme Wood; Susan Whitfield-Gabrieli; Feng Wan; Patrik Vuilleumier; François Vialatte; Dimitri Van De Ville; Doron Todder; Tanju Surmeli; James S Sulzer; Ute Strehl; Maurice Barry Sterman; Naomi J Steiner; Bettina Sorger; Surjo R Soekadar; Ranganatha Sitaram; Leslie H Sherlin; Michael Schönenberg; Frank Scharnowski; Manuel Schabus; Katya Rubia; Agostinho Rosa; Miriam Reiner; Jaime A Pineda; Christian Paret; Alexei Ossadtchi; Andrew A Nicholson; Wenya Nan; Javier Minguez; Jean-Arthur Micoulaud-Franchi; David M A Mehler; Michael Lührs; Joel Lubar; Fabien Lotte; David E J Linden; Jarrod A Lewis-Peacock; Mikhail A Lebedev; Ruth A Lanius; Andrea Kübler; Cornelia Kranczioch; Yury Koush; Lilian Konicar; Simon H Kohl; Silivia E Kober; Manousos A Klados; Camille Jeunet; T W P Janssen; Rene J Huster; Kerstin Hoedlmoser; Laurence M Hirshberg; Stephan Heunis; Talma Hendler; Michelle Hampson; Adrian G Guggisberg; Robert Guggenberger; John H Gruzelier; Rainer W Göbel; Nicolas Gninenko; Alireza Gharabaghi; Paul Frewen; Thomas Fovet; Thalía Fernández; Carlos Escolano; Ann-Christine Ehlis; Renate Drechsler; R Christopher deCharms; Stefan Debener; Dirk De Ridder; Eddy J Davelaar; Marco Congedo; Marc Cavazza; Marinus H M Breteler; Daniel Brandeis; Jerzy Bodurka; Niels Birbaumer; Olga M Bazanova; Beatrix Barth; Panagiotis D Bamidis; Tibor Auer; Martijn Arns; Robert T Thibault
Journal:  Brain       Date:  2020-06-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.